Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „BCRP“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol
Eintrag öffnenBrilique · 4.5 · Rosuvastatin (BCRP substrate) Ticagrelor has been shown to increase rosuvastatin Cmax by approximately 2.5-fol
Eintrag öffnenCalquence · 4.5 · Acalabrutinib may increase exposure to co-administered BCRP substrates (e.g., methotrexate) by inhibition of i
Eintrag öffnenCalquence · 4.5 · Acalabrutinib may increase exposure to co-administered BCRP substrates (e.g., methotrexate) by inhibition of i
Eintrag öffnenCholib · 4.5 · Inhibitors of Breast Cancer Resistant Protein (BCRP) Concomitant administration of medicinal products that are
Eintrag öffnenCholib · 4.5 · Inhibitors of Breast Cancer Resistant Protein (BCRP) Concomitant administration of medicinal products that are
Eintrag öffnenCotellic · 4.5 · BCRP substrates
Eintrag öffnenCotellic · 4.5 · In vitro, cobimetinib is a moderate inhibitor of BCRP (Breast Cancer Resistance Protein). No clinical DDI stud
Eintrag öffnenCresemba · 4.5 · Isavuconazole is an inhibitor in vitro of BCRP, and plasma concentrations of substrates of BCRP may therefore
Eintrag öffnenCresemba · 4.5 · Isavuconazole is an inhibitor in vitro of BCRP, and plasma concentrations of substrates of BCRP may therefore
Eintrag öffnenCresemba · 4.5 · Medicinal products transported by BCRP
Eintrag öffnenDarunavir Krka · 4.5 · 54 (P-gp, BCRP and/or OATP1B1/3 inhibition) HERBAL PRODUCTS St John's wort (Hypericum Not studied. St John's w
Eintrag öffnenDescovy · 4.5 · Tenofovir alafenamide is transported by P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). Med
Eintrag öffnenDescovy · 4.5 · Tenofovir alafenamide is transported by P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP). Med
Eintrag öffnenDovato · 4.5 · Although lamivudine is a substrate of BCRP and P-gp in vitro, given its high absolute bioavailability, (see se
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.5 · Effect on OAT3, OATP1B3, P-gp and BCRP substrates Pretomanid is an inhibitor of the OAT3 transporter in vitro,
Eintrag öffnenDovprela (previously Pretomanid FGK) · 4.5 · In vitro studies indicate that pretomanid is an inhibitor of BCRP, OATP1B3 and P-gp. No clinical studies have
Eintrag öffnenEnzalutamide Viatris · 4.5 · BCRP substrates At steady-state, enzalutamide did not cause a clinically meaningful change in exposure to the
Eintrag öffnenEpclusa · 4.5 · 38 medicinal product interactions with Epclusa mediated by P-gp, BCRP, OATP, or CYP450 inhibitors are not expe
Eintrag öffnenEpclusa · 4.5 · Sofosbuvir and velpatasvir are substrates of drug transporters P-gp and BCRP. Velpatasvir is also a substrate
Eintrag öffnen